How will the pharmaceutical industry evolve on drug pricing?

High drug prices are a constant consumer complaint about health care. Judy Woodruff sits down with Stephen Ubl, president and CEO of the Pharmaceutical Research and Manufacturers Association, at the Spotlight Health Conference at the Aspen Institute to discuss the Republican health care bill, the prospects for lowering drug prices and the connection between the opioid crisis and the industry.